Akero Therapeutics
AKRO
#3352
Rank
A$5.10 B
Marketcap
$64.09
Share price
3.48%
Change (1 day)
105.53%
Change (1 year)

Akero Therapeutics (AKRO) - Cash on Hand

Cash on Hand as of December 2024 : A$1.16 Billion

According to Akero Therapeutics's latest financial reports the company has A$1.16 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Akero Therapeutics - Cash on Hand chart (from 2018 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$1.19 B47.98%
2023-12-31A$0.80 B56.31%
2022-12-31A$0.51 B98.89%
2021-12-31A$0.25 B-25.6%
2020-12-31A$0.34 B79.16%
2019-12-31A$0.19 B80.64%
2018-12-31A$0.10 B13979.58%
2017-12-31A$0.76 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.40 B-65.55%๐Ÿ‡บ๐Ÿ‡ธ USA